StockDriftsStockDriftsTop 9 ARCH Venture Management, LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| MAZE | MAZE THERAPEUTICS INC | 18.16% | 4.12M | $123.0M | +0.00%(+0) | $11.01(+183.92%) | 2026-03-31 | |
| RAPP | RAPPORT THERAPEUTICS INC | 17.23% | 3.73M | $116.7M | +0.00%(+0) | $23.26(+67.54%) | 2026-03-31 | |
| VIR | VIR BIOTECHNOLOGY INC | 17.09% | 12.92M | $115.7M | +0.00%(+0) | $5.87(+71.04%) | 2026-03-31 | |
| ERAS | ERASCA INC | 16.95% | 7.09M | $114.7M | -35.86%(-3.96M) | $18.40(+0.38%) | 2026-03-31 | |
| BEAM | BEAM THERAPEUTICS INC | 15.98% | 4.54M | $108.2M | +0.00%(+0) | $28.24(+23.22%) | 2026-03-31 | |
| LYEL | LYELL IMMUNOPHARMA INC | 9.62% | 3.25M | $65.1M | +17.69%(+488.09K) | $12.96(+8.44%) | 2026-03-31 | |
| TXG | 10X GENOMICS INC | 0.68% | 217.8K | $4.6M | -70.46%(-519.71K) | $14.00(+178.64%) | 2026-03-31 | |
| GOSS | GOSSAMER BIO INC | 0.39% | 8.06M | $2.6M | +0.00%(+0) | $1.02(-82.96%) | 2026-03-31 | |
| QTTB | Q32 BIO INC | 0.3% | 320.5K | $2.1M | +0.00%(+0) | $13.99(-6.45%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +14.61% | +50.55% |
| Top 20 Holdings Unweighted | +33.50% | +137.94% |
Sign up free to track ARCH Venture Management, LLC, compare funds side by side, and get alerts the moment positions change.